AMGN
Amgen Inc. · Healthcare · Drug Manufacturers - General
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 169 | -1 | 364.70M | $131.99B | +5 | −7 |
| Q1 2026 | 174 | -2 | 366.40M | $128.82B | +4 | −7 |
| Q4 2025 | 175 | 0 | 394.29M | $128.98B | +2 | −1 |
| Q3 2025 | 26 | 0 | 206.42M | $58.23B | — | −1 |
| Q2 2025 | 24 | +1 | 183.25M | $51.15B | +2 | −1 |
| Q1 2025 | 20 | -2 | 81.79M | $25.47B | — | −2 |
| Q4 2024 | 22 | +2 | 74.78M | $19.48B | +2 | — |
| Q3 2024 | 19 | -1 | 39.65M | $12.76B | +1 | −2 |
| Q2 2024 | 20 | — | 39.58M | $12.36B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 14.45M | — | $4.51B | 3.3% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasif) | 12.02M | — | $3.75B | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (pasif) | 5.81M | — | $1.81B | 0.3% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 4.52M | — | $1.41B | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 5 | Marshall Wace ✦ | 656.50K | — | $205.12M | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 6 | Adage Capital Partners ✦ | 578.30K | — | $180.69M | 0.3% | n/c | 1 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 542.15K | — | $169.39M | 0.4% | n/c | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 306.68K | — | $95.82M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 9 | Wellington Management ✦ | 234.41K | — | $73.24M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 10 | Fisher Asset Management ✦ | 84.38K | — | $26.36M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | ARK Investment Management ✦ | 74.82K | — | $23.38M | 0.2% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 73.12K | — | $22.85M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 13 | Millennium Management ✦ | 67.21K | — | $21.00M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 52.24K | — | $16.32M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 37.27K | — | $11.65M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 22.81K | — | $7.13M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 22.14K | — | $6.92M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Dodge & Cox ✦ | 14.38K | — | $4.49M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 8.73K | — | $2.73M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 5.59K | — | $1.75M | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 3,100 pemegang, 420.54M saham, $144.29B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 1.25K lbr · $521,365
Officer · 2.00K lbr · $825,134
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi